☆ 4.7 Letter

BAL Is Safe and Well Tolerated in Individuals with Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Get Full Text
Add to Collection

Journal

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 203, Issue 1, Pages 136-139

Publisher

AMER THORACIC SOC
DOI: 10.1164/rccm.202004-1138LE

Keywords

-

Categories

Critical Care Medicine Respiratory System

Funding

  1. National Institute for Health Research Research Professorship [RP-2017-08-ST2-014]
  2. National Institute for Health Research Clinician Scientist Fellowship [CS-2013-13-017]
  3. British Lung Foundation Chair in Respiratory Research [C17-3]
  4. Medical Research Council [G0901226]
  5. GlaxoSmithKline RD [CRT114316]
  6. Nottingham University
  7. Royal Brompton and Harefield National Health Service Foundation Trust
  8. National Institutes of Health Research (NIHR) [RP-2017-08-ST2-014] Funding Source: National Institutes of Health Research (NIHR)

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.